Vaqta Injection, Suspension
NDC Package 0006-4095-02
Package Information
Vaqta (hepatitis a vaccine, inactivated) injection is vAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. This formulation utilizes a injection, suspension delivery system. Marketed by Merck Sharp & Dohme Llc, this product is identified by NDC 0006-4095 and is authorized under FDA application BLA103606.
Identification & Billing
- RxCUI: 1658100 - hepatitis A virus strain CR 326F antigen, inactivated adult (HepA) 50 UNT in 1 mL Injection
- RxCUI: 1658100 - 1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection
- RxCUI: 1658102 - VAQTA adult vaccine 1 ML Injection
- RxCUI: 1658102 - 1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection [Vaqta]
- RxCUI: 1658102 - 1 ML Vaqta 50 UNT/ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0006 - Merck Sharp & Dohme Llc
- 0006-4095 - Vaqta
- 0006-4095-02 - 10 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE (0006-4095-01)
- 0006-4095 - Vaqta
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0006-4095-02 identifies a specific commercial package of 10 syringe in 1 carton / .5 ml in 1 syringe (0006-4095-01) of Vaqta, a vaccine label labeled by Merck Sharp & Dohme Llc. This product is billed per "ML" milliliter and contains an estimated amount of 5 billable units per package. This injection, suspension is formulated for intramuscular use and contains hepatitis a virus strain cr 326f antigen (formaldehyde inactivated) as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Merck Sharp & Dohme Llc on March 29, 1996. The current certification is valid through December 31, 2027.
How is this Merck Sharp & Dohme Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00006409502. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.